PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers, predicting patient outcomes with over 90% accuracy. Backed by top Pharma, PredxBio’s SpaceIQ platform accelerates drug discovery, de-risks clinical trials, and addresses a $100B+ market in precision medicine.